904 Caribbean Drive
United States - Map
Cepheid, a molecular diagnostics company, develops, manufactures, and markets integrated systems for testing in the clinical market; and for application in legacy non-clinical market. Its systems enable molecular testing for organisms and genetic-based diseases by automating manual laboratory procedures. The company offers GeneXpert system that integrates sample preparation in addition to DNA amplification and detection; and SmartCycler system, which integrates DNA amplification and detection to allow rapid analysis of a sample. The GeneXpert system is designed for reference laboratories, hospital central laboratories, and satellite testing locations, such as emergency departments and intensive care units within hospitals and doctors offices. Cepheid also provides GeneXpert Infinity System for high volume testing. The company offers tests for the GeneXpert and the SmartCycler systems in the areas of healthcare associated infections, critical infectious disease, sexual health, womens health, virology, oncology, and genetics. Cepheid sells its products through its direct sales force and through third-party distributors worldwide. It has collaboration agreements with Novartis for the commercialization of a test for monitoring the BCR-ABL gene transcript in peripheral blood specimens; and Life Technologies Corporation to develop reagents for use in the USPS BDS program. The company was founded in 1996 and is headquartered in Sunnyvale, California.
|Mr. John L. Bishop ,
Chairman, Chief Exec. Officer and Member of Equity Incentive Committee
|Mr. Thomas L. Gutshall ,
Co-Founder and Director
|Mr. Andrew D. Miller ,
Chief Financial Officer, Principal Accounting Officer and Exec. VP
|Dr. David H. Persing M.D., Ph.D.,
Chief Medical & Technology Officer, Exec. VP, Director and Member of Equity Incentive Committee
|Mr. Joseph H. Smith Esq.,
Exec. VP of Corp. Devel., Gen. Counsel and Sec.
|Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|